IP Library Granted Patent US 8,685,406
Granted Patent B2
US 8,685,406 · App. 12/927,220 · Granted Apr 1, 2014

Compositions of and method of using heat shock protein peptides

Inventors: David H. Walker (Galveston, TX); Sunil Thomas (Dickinson, TX)
Assignee: The Board of Regents of the University of Texas System
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,685,406
App. No.
12/927,220
Granted
Apr 1, 2014
Kind
B2
Abstract

The present invention provides an isolated and purified heat shock protein 60 (Hsp60) peptide having the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to a vaccine against Ehrlichia comprising a peptide homologous to the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to an antibody directed against a peptide homologous to the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to a method of determining whether a subject is infected with Ehrlichia , comprising the steps of: contacting a sample from a subject with the antibody described herein; and detecting a resulting antibody reaction, wherein a positive reaction indicates the subject is infected with Ehrlichia.

Claims (12)

1. An isolated heat shock protein 60 peptide having at most 21 amino acids that is at least 80% identical to the amino acid sequence of SEQ ID NO:2.

2. The peptide of claim 1 , wherein the amino acid sequence of the peptide is at least 90% identical to the amino acid sequence of SEQ ID NO:2.

3. The peptide of claim 1 , wherein the amino acid sequence of the peptide is at least 95% identical to the amino acid sequence of SEQ ID NO:2.

4. The peptide of claim 1 , wherein said peptide has the amino acid sequence of SEQ ID NO:2.

5. The peptide of claim 1 , further comprising a label.

6. The peptide of claim 1 , wherein said peptide further comprises a carrier.

7. The peptide of claim 6 , wherein said peptide is conjugated to said carrier.

8. The peptide of claim 7 , wherein said peptide and carrier are conjugated by glutaraldehyde, m-maleimidobenzoyl-N-hydroxy-succinimide ester, carbo-diimide or bis-biazotized benzidine.

9. The peptide of claim 6 , wherein said carrier is keyhole limpet hemocyanin, human serum albumin, a lymphokine, or an adjuvant.

10. The peptide of claim 9 , wherein the adjuvant is IL2, IL4, IL8, BCG, Detox, 5 RIBI, ISCOMS, or aluminum hydroxide.

11. A method of inducing an immune response against Ehrlichia comprising administering to a subject the peptide of claim 1 .

12. The method of claim 11 , wherein said Ehrlichia is selected from the group consisting of Ehrlichia chaffeensis, Ehrlichia muris, Ehrlichia ewingii, Ehrlichia ruminantium and Ehrlichia canis.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2010
From: WALKER, DAVID H.; THOMAS, SUNIL
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, THE
Reel/Frame 025314/0628 →
Continuity (2)
Provisional Application 61281178 · Nov 13, 2009
Related Publication 20110117130A1 · May 19, 2011